Iizuka Ryo
Graduate School of Pharmaceutical Sciences, The University of Tokyo.
Yakugaku Zasshi. 2020;140(11):1299-1303. doi: 10.1248/yakushi.20-00111.
The author has developed several methodological approaches that use nanophotonic and microfluidic devices to accelerate pharmaceutical research and development. Here, the author describes two of these approaches and provides practical examples. The first is a nanophotonic approach to break the concentration limit of diffusing fluorophore-labeled molecules in single-molecule imaging. Although single-molecule imaging is highly useful in characterizing the kinetics of biomolecular interactions, it requires nanomolar concentrations of labeled molecules in solution. Zero-mode waveguides are nanophotonic structures that reduce the illumination volume by more than three orders of magnitude relative to conventional fluorescence microscopy, thereby allowing single-molecule investigations at micromolar to millimolar concentrations of fluorescent molecules i.e., under near-physiological conditions. The second approach is microfluidic microdroplet-based, allowing the discovery of novel biomolecules with the desired activities. Microfluidics allows the ultrarapid production of monodisperse microdroplets such as water-in-oil microdroplets. Each microdroplet serves as a nano/picoliter-volume test tube, which increases assay sensitivity by increasing the effective concentration of molecules and decreasing the time required to reach detection thresholds. I hope you find this review helpful in your research.
作者开发了几种方法,利用纳米光子学和微流控设备来加速药物研发。在此,作者描述了其中两种方法并给出了实际例子。第一种是纳米光子学方法,用于突破单分子成像中扩散的荧光团标记分子的浓度限制。尽管单分子成像在表征生物分子相互作用的动力学方面非常有用,但它需要溶液中纳摩尔浓度的标记分子。零模式波导是一种纳米光子学结构,相对于传统荧光显微镜,它将照明体积减少了三个以上数量级,从而能够在微摩尔到毫摩尔浓度的荧光分子下,即在接近生理条件下进行单分子研究。第二种方法基于微流控微滴,可用于发现具有所需活性的新型生物分子。微流控技术能够超快速地产生单分散微滴,如水包油微滴。每个微滴都充当一个纳升/皮升体积的试管,通过提高分子的有效浓度和缩短达到检测阈值所需的时间来提高检测灵敏度。希望这篇综述对您的研究有所帮助。